Our Services
Medical Information
Helpful Resources
Published on: 1/4/2026
Guanfacine is an FDA-approved medication used to treat ADHD in children, adolescents, and adults (as extended-release Intuniv) and high blood pressure (as immediate-release Tenex).
It is also prescribed off-label for tics, sleep disturbances, behavioral dysregulation, and PTSD-related hyperarousal. Before starting or adjusting guanfacine, patients should consider potential side effects, drug interactions, blood pressure changes, and the importance of tapering rather than stopping abruptly.
If you're experiencing symptoms that may be related to ADHD, anxiety, high blood pressure, or another underlying condition, understanding what's driving them is the critical first step. A free, instant, AI-powered symptom check can help you identify possible causes, clarify whether guanfacine or another treatment path might be relevant, and guide your next conversation with a healthcare provider—so you can move forward with clarity and confidence.
Reviewed for medical accuracy: 07/09/2026
Not seeing your question? No worries.
Submit your own QuestionWhat Is Guanfacine Used For?
Guanfacine is a prescription medicine that acts on specific receptors in the brain to help regulate attention, impulse control, and blood pressure. It belongs to a class of drugs called centrally acting α₂-adrenergic agonists. While first approved for treating high blood pressure, guanfacine is now most widely used (and studied) for attention-deficit/hyperactivity disorder (ADHD) in children, adolescents, and adults. Below is an overview of its main uses, how it works, dosing considerations, common side effects, and important warnings.
Attention-Deficit/Hyperactivity Disorder (ADHD)
High Blood Pressure (Hypertension)
Off-Label Uses
Mechanism of Action
• Stimulates α₂A-adrenergic receptors in the prefrontal cortex of the brain
• Enhances "top-down" regulation of attention, working memory, and impulse control
• Decreases sympathetic nerve outflow, lowering heart rate and blood pressure
Pharmacokinetics
• Well absorbed (80–90%) after oral dosing
• Peak levels:
– Immediate-release: 1–4 hours
– Extended-release: 5–7 hours
• Elimination half-life: 17 hours (extended-release), allowing once-daily dosing
| Formulation | Typical Starting Dose | Maximum Dose | Dosing Schedule |
|---|---|---|---|
| Immediate-Release | 1 mg once daily (morning or bedtime) | 3 mg/day (divided doses) | Twice or thrice daily |
| Extended-Release | 1 mg once daily (morning) | 4 mg/day | Once daily, morning |
Most side effects are mild to moderate and often improve after a few weeks of use:
If side effects become bothersome or persist beyond 2–4 weeks, speak with your doctor about dose adjustment or alternative therapies.
Blood Pressure & Heart Rate
• Can cause hypotension (low blood pressure) and bradycardia (slow heart rate)
• Monitor vital signs regularly, especially when starting or increasing dose
Rebound Hypertension
• Abrupt discontinuation may lead to rapid increase in blood pressure and heart rate
• Taper off gradually over at least 1–2 weeks under medical supervision
Sedation & Dizziness
• Avoid driving or operating machinery until you know how guanfacine affects you
Drug Interactions
• Additive blood pressure lowering with other antihypertensives, alcohol
• Caution when used with CNS depressants (benzodiazepines, opioids)
Special Populations
• Children: Extended-release form approved down to age 6 for ADHD
• Older Adults: May be more sensitive to hypotensive effects; start at lower doses
• Pregnancy & Breastfeeding: Limited data; weigh benefits vs. risks
Initial Evaluation
• Baseline blood pressure and heart rate
• ADHD symptom rating scales (for ADHD use)
Ongoing
• Check blood pressure/heart rate: every 1–2 weeks during titration, then every 3–6 months
• Monitor growth (height/weight) in children
• Reassess ADHD symptoms and side effects regularly
For any potentially life-threatening or serious concerns, always speak to a doctor or visit your nearest emergency department.
If you're wondering whether your symptoms could be related to high blood pressure or want to understand your condition better before your doctor's appointment, Ubie's free AI-powered symptom checker can help you assess your health concerns in just a few minutes.
Remember: This information is meant to supplement—not replace—professional medical advice. Always consult your doctor or pharmacist before starting, changing, or stopping any medication.
(References)
Scahill L, Chappell PB, Kim YS, Schultz RT, Katsovich L, Shepherd E, Schulz S, Donnelly R, Riddle MA. (2001). A placebo-controlled pilot study of guanfacine in the trea… Journal of the American Academy of Child & Adolescent Psychiatry, 11391022.
Castera L, Forns X, Alberti A. (2008). Noninvasive evaluation of liver fibrosis using transient ele… Journal of Hepatology, 18338519.
Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, Burroughs AK. (2014). Elastography for the diagnosis of severity of fibrosis in chroni… Clin Gastroenterol Hepatol, 23849133.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.